Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis

OBJECTIVE: The clinical course of multiple sclerosis (MS) is variable and largely unpredictable pointing to an urgent need for markers to monitor disease activity and progression. Recent evidence revealed that tissue transglutaminase (TG2) is altered in patient-derived monocytes. We hypothesize that...

Descripción completa

Detalles Bibliográficos
Autores principales: Sestito, Claudia, Leurs, Cyra E., Steenwijk, Martijn D., Brevé, John J.P., Twisk, Jos W.R., Wilhelmus, Micha M.M., Drukarch, Benjamin, Teunissen, Charlotte E., van Dam, Anne-Marie, Killestein, Joep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105890/
https://www.ncbi.nlm.nih.gov/pubmed/33906937
http://dx.doi.org/10.1212/NXI.0000000000000998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105890/
https://www.ncbi.nlm.nih.gov/pubmed/33906937
http://dx.doi.org/10.1212/NXI.0000000000000998

Ejemplares similares